Who Paid My Doc
Atellica IM 1300 Analyzer
Device DX - Diagnostics incl. all products and services
PDI 00630414007960
General payments
$116,863
Research payments
$1,281,760
Through program year 2025, $116,863 in general payments and $1,281,760 in research payments were reported against Atellica IM 1300 Analyzer (DX - Diagnostics incl. all products and services).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $80,980 | 101 |
| 2025 | Research | $291,819 | 4 |
| 2024 | General | $11,385 | 81 |
| 2024 | Research | $353,048 | 10 |
| 2023 | General | $4,330 | 73 |
| 2023 | Research | $221,018 | 6 |
| 2022 | General | $6,859 | 28 |
| 2022 | Research | $37,253 | 3 |
| 2021 | General | $13,309 | 61 |
| 2021 | Research | $378,623 | 16 |
Breakdown
The top 5 of 59 recipients; each share is of general payments naming this product in 2025.
The top 5 of 24 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 23 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
344 general · 39 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.